Dr Patricia Rawlins, MD in Towson, MD - Medicare Hospitalist

Dr Patricia Rawlins, MD is a medicare enrolled "Hospitalist" physician in Towson, Maryland. She graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Hospitalist. She is a member of the group practice University Of Maryland St Joseph Medical Group Llc and her current practice location is St. Joseph Medical Center, 7601 Osler Drive, Towson, Maryland. You can reach out to her office (for appointments etc.) via phone at (410) 337-1379.

Dr Patricia Rawlins is licensed to practice in Maryland (license number D0065753) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1184742603.

Contact Information

	Dr Patricia Rawlins, MD
	St. Joseph Medical Center, 7601 Osler Drive, Towson, MD 21204
	(410) 337-1379
	Not Available

Physician's Profile

Full Name	Dr Patricia Rawlins
Gender	Female
Speciality	Hospitalist
Experience	20 Years
Location	St. Joseph Medical Center, Towson, Maryland
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Patricia Rawlins graduated from medical school in 2004

NPI Data:

NPI Number: 1184742603
Provider Enumeration Date: 03/26/2007
Last Update Date: 06/30/2017

Medicare PECOS Information:

PECOS PAC ID: 1254423478
Enrollment ID: I20070817000323

Medical Identifiers

Medical identifiers for Dr Patricia Rawlins such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1184742603	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	D0065753 (Maryland)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
University Of Md St Joseph Medical Center	Towson, MD	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
University Of Maryland St Joseph Medical Group Llc	4880846179	224

News Archive

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Selexys Pharmaceuticals announced today that it has completed a Phase I clinical study of its lead compound SelG1, an antibody specific for the pro-inflammatory cell adhesion molecule P-selectin.

Discovery of protein fragment that helps predict breast cancer outcome

Oregon Health & Science University Cancer Institute researchers have identified a protein fragment in some human breast cancers that may help predict a patient's chances of survival.

Diabetes and glucose levels tied to increased risk of COVID-19 death

Researchers at Xijing Hospital, Fourth Military Medical University, Xi'an, China, found that diabetes and on-admission glucose levels may increase the risk of COVID-19 mortality.

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Researchers have identified a mechanism that allows cancer cells to respond and grow rapidly when levels of sugar in the blood rise. This may help to explain why people who develop conditions in which they have chronically high sugar levels in their blood, such as obesity, also have an increased risk of developing certain types of cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Patricia Rawlins allows following entities to bill medicare on her behalf.

Entity Name	University Of Maryland St Joseph Medical Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1770836785 PECOS PAC ID: 4880846179 Enrollment ID: O20121213000234

News Archive

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Selexys Pharmaceuticals announced today that it has completed a Phase I clinical study of its lead compound SelG1, an antibody specific for the pro-inflammatory cell adhesion molecule P-selectin.

Discovery of protein fragment that helps predict breast cancer outcome

Oregon Health & Science University Cancer Institute researchers have identified a protein fragment in some human breast cancers that may help predict a patient's chances of survival.

Diabetes and glucose levels tied to increased risk of COVID-19 death

Researchers at Xijing Hospital, Fourth Military Medical University, Xi'an, China, found that diabetes and on-admission glucose levels may increase the risk of COVID-19 mortality.

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Patricia Rawlins is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Patricia Rawlins, MD 4 Berkley Ct, Freeland, MD 21053-9447 Ph: (410) 357-8323	Dr Patricia Rawlins, MD St. Joseph Medical Center, 7601 Osler Drive, Towson, MD 21204 Ph: (410) 337-1379

News Archive

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Selexys Pharmaceuticals announced today that it has completed a Phase I clinical study of its lead compound SelG1, an antibody specific for the pro-inflammatory cell adhesion molecule P-selectin.

Discovery of protein fragment that helps predict breast cancer outcome

Oregon Health & Science University Cancer Institute researchers have identified a protein fragment in some human breast cancers that may help predict a patient's chances of survival.

Diabetes and glucose levels tied to increased risk of COVID-19 death

Researchers at Xijing Hospital, Fourth Military Medical University, Xi'an, China, found that diabetes and on-admission glucose levels may increase the risk of COVID-19 mortality.

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Hospitalist Doctors in Towson, MD

Dr. James Womer, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 443-849-2000
Dr. Joseph Michael Nogueira, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-427-2574 Fax: 410-427-2054
Ramona Ramachandran, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Greater Baltimore Medical Center, Towson, MD 21204 Phone: 443-849-2983 Fax: 410-849-3776
Dr. Mojgan Sohi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 312-929-6864
Tatek Teshome, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 888-989-1144
Dr. Irina Mikityanskaya, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-427-2574

Dr Patricia Rawlins, MD - Medicare Hospitalist in Towson, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Discovery of protein fragment that helps predict breast cancer outcome

Diabetes and glucose levels tied to increased risk of COVID-19 death

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Medicare Reassignments

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Discovery of protein fragment that helps predict breast cancer outcome

Diabetes and glucose levels tied to increased risk of COVID-19 death

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Phase I clinical study of Selexys SelG1 for sickle cell disease completed

Discovery of protein fragment that helps predict breast cancer outcome

Diabetes and glucose levels tied to increased risk of COVID-19 death

Researchers identify mechanism that allows cancer cells to grow rapidly when blood sugar levels rise

Hospitalist Doctors in Towson, MD